Tender Details

Particulars Details
Title
Cetuximab 100 Mg Inj,Pertuzumab Vial Of 420 Mg Inj,Temozolamide 100 Mg Cap,Pneumococcal Polysacchari
Description
Organisation Department of Military Affairs | Ministry of Defence
Tender Id GEM/2025/B/6356815
Reference
Number
Tender Fee
EMD
Tender Value
Place
Link
View Original Tender Notice

https://bidplus.gem.gov.in/all-bids

Start Date July 05, 2025 17:31
End Date
Expired 23/07/2025

Expired 316 days ago

Search Similar tenders?

Tender Support

Get help with filing, GeM registration, documents, or relevant tender alerts.

Tender Result
Tender Status: Active
Additional Information: Average Turn Over of Last 3 Years: 60 Lakhs Experience with Gov. Required: Years
Buyer Details
Name: ***********
Address: *********** PUNE
Ministry: Ministry Of Defence
Department: Department Of Military Affairs
Organisation: Indian Army
Office Address: ***********
Similar Tenders
Pertuzumab inj 420 mg vial

For complete deion and other details, please refer to tender

Read more
Cetuximab 100mg inj in vial

For complete deion and other details, please refer to tender

Read more
Cetuximab 100mg inj in vial

For complete deion and other details, please refer to tender

Read more
Cetuximab 100mg inj in vial

For complete deion and other details, please refer to tender

Read more
Cetuximab 100mg inj in vial

For complete deion and other details, please refer to tender

Read more
Running contract for inj. pertuzumab 420 mg/14ml in vial packing.

For complete deion and other details, please refer to tender

Read more
Running contract of inj. pertuzumab 420 mg/14 ml in vial packing.

For complete deion and other details, please refer to tender

Read more
Running contract of inj. pertuzumab 420 mg/14 ml in vial packing.

For complete deion and other details, please refer to tender

Read more
Running contract of inj. pertuzumab 420 mg/14 ml in vial packing.

For complete deion and other details, please refer to tender

Read more
Click Here to Download Dockets
of your Industry type
Get customized tender Recommendations for your Enterprise